Ibritumomab Intravenous and UTA Capsules
Determining the interaction of Ibritumomab Intravenous and UTA Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-UTAC tablets
- Ibritumomab Intravenous-UTI Relief
- Ibritumomab Intravenous-Utibron Neohaler
- Ibritumomab Intravenous-Uticap
- Ibritumomab Intravenous-Utira-C
- Ibritumomab Intravenous-Utira-C Tablets
- UTA Capsules-Ibritumomab Tiuxetan
- UTA Capsules-Ibrutinib
- UTA Capsules-Ibrutinib Capsules
- UTA Capsules-Ibrutinib Tablets
- UTA Capsules-Ibu
- UTA Capsules-IBU Tablets